Evaluation Findings - SAMHSA Store - Substance Abuse and Mental ...
Evaluation Findings - SAMHSA Store - Substance Abuse and Mental ...
Evaluation Findings - SAMHSA Store - Substance Abuse and Mental ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table E-7: Baseline Characteristics: Child History <strong>and</strong> Family Characteristics<br />
for Grant Communities Funded in 2002–2004 (continued)<br />
Grant Communities Funded in 2002–2004<br />
Outcome Sample (n = 4,271)<br />
Family Poverty Level (n = 3,691)<br />
Below Poverty 58.0%<br />
At Poverty 17.2%<br />
Above Poverty 24.8%<br />
Child Medication Use 47.5% (n = 4,038)<br />
Current Medications (n = 1,858)<br />
Abilify 14.4%<br />
Adderall 17.8%<br />
Benzodiazepine 0.2%<br />
Carbamazepine 0.4%<br />
Catapres 6.8%<br />
Celexa 1.9%<br />
Klonopin 2.0%<br />
Concerta 15.7%<br />
Depakote 11.5%<br />
Desyrel 3.1%<br />
Dexedrine 0.9%<br />
Effexor 1.1%<br />
Haldol 0.4%<br />
Lexapro 5.1%<br />
Lamictal 2.4%<br />
Lithium 4.7%<br />
Neurontin 0.4%<br />
Orap 0.1%<br />
Paxil 1.7%<br />
Prozac 7.9%<br />
Risperdal 18.5%<br />
Ritalin 7.5%<br />
Seroquel 14.9%<br />
Stratera 9.8%<br />
Symbiax 0.2%<br />
Tenex 3.8%<br />
Trileptal 4.5%<br />
Wellbutrin 5.6%<br />
Xanax 0.2%<br />
Zoloft 7.0%<br />
Zyprexa 2.7%<br />
Other 21.7%<br />
The Comprehensive Community <strong>Mental</strong> Health Services for Children <strong>and</strong> Their Families Program <strong>Evaluation</strong> <strong>Findings</strong><br />
2006–08 Annual Report to Congress ● Appendix E ● Page 22